RS-61443 for treatment-resistant human liver rejection.
Klintmalm
G B
GB
Department of Surgery, Baylor University Medical Center, Dallas, Texas.
Ascher
N L
NL
Busuttil
R W
RW
Deierhoi
M
M
Gonwa
T A
TA
Kauffman
R
R
McDiarmid
S
S
Poplawski
S
S
Sollinger
H
H
Roberts
J
J
D000208:Acute Disease; D001379:Azathioprine / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D004351:Drug Resistance; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016031:Liver Transplantation / Q000276:immunology*; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010865:Pilot Projects; D011239:Prednisolone / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D011239:Prednisolone; D009173:Mycophenolic Acid; D001379:Azathioprine